BMP Sunstone Corporation (BJGP)

BMP Sunstone Corporation operates as a pharmaceutical and over-the-counter, or OTC, manufacturing, marketing, and distribution company in China. It offers various marketing and promotional services, including pre-market entry analysis; clinical trial management; product registration; market research; pharmaceutical marketing to physicians, hospitals, and other healthcare providers; OTC marketing to retail pharmacies; and pharmaceutical distribution. The company also provides distribution services for various products, including western medicines, traditional Chinese medicines, bio-chemical medicines, and medical applications. BMP Sunstone's products include Propess for the treatment of cervical ripening; Anpo for pre-term labor management; and Galake for cancer, trauma, and surgical pains. The company's developing products include Ferriprox for iron overload; Flashtab Ondansetron for nausea and vomiting; Clindesse for bacterial vaginosis; Enablex for overactive bladder; Misopess for cervical ripening and labor induction; Fentora for pain management; Nuvigil for excessive sleepiness; and Myocet for breast cancer. Its OTC products consist of Hao Wawa pediatric granules, chewables, and syrups; Kang Fu Te line of gynecology suppositories; and Nemei line of women's health products. The company was formerly known as Beijing Med-Pharm Corporation and changed its name to BMP Sunstone Corporation in February 2008. BMP Sunstone is based in Plymouth Meeting, Pennsylvania.

For the six months ended 30 June 2006, Beijing Med-Pharm Corporation's revenues totaled $10.1M, up from $101K. Net loss increased 23% to $3.1M. Revenues reflect an increase in sales due to the acquisition of Wanwei in October 2005. Higher loss reflects an increase in cost of sales due to acquisition of Wanwei, higher sales & marketing expenses, an increase in general & administrative expenses and the presence of interest expense.